Award
Delivery Order #SPE2DR26F4G5P
Pharmaceutical Delivery Order for Guanfacine HCL Tablets to AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$225.48
Ceiling
$225.48
Awarded
February 13, 2026
Period of Performance
Feb 13, 2026 – Feb 17, 2026
Identifier
SPE2DR26F4G5P
NAICS
424210
This award is a delivery order contract under the existing indefinite delivery vehicle (IDV) held by AmerisourceBergen Drug Corp, a leading pharmaceutical sourcing and distribution company. The contract entails the procurement of Guanfacine HCL ER 1 mg tablets, a critical medication, reinforcing the company's role in supplying essential pharmaceuticals to healthcare entities. The significance of this order lies in its contribution to maintaining uninterrupted access to vital medications within the public health sector. The scope covers the delivery of specified medication units to a designated location in Conshohocken, Pennsylvania, under a short-term schedule lasting a few days in early 2026. This order supports the overarching IDV that facilitates pharmaceutical distribution services, ensuring reliable logistics and supply chain operations. The contract was awarded through established channels under the parent IDV agreement, reflecting a streamlined procurement process rather than competitive bidding for this specific delivery. Overall, this delivery order exemplifies continuous support for public healthcare needs by effectively managing pharmaceutical supplies within a multi-year framework.
Description
4570837221!GUANFACINE HCL ER 1 MG TABLET 100S